(844) 794.3637 EXT 100
Customizing a patient's medication to the way their individual body metabolizes medications decreases the amount of time it takes them to become therapeutic as well as reducing the overall occurrences of Adverse Drug Events (ADE). Both of these are critically important in reducing the time spent in the hospital and lowering readmission rates, thereby improving the bottom line.
Most hospitals do not have the technology necessary to do gene sequencing nor the luxury of time. The proper path, wherever possible, is to gain the acceptance of the referring physician network in the process of collecting this data. For at risk patients, physicians would order pharmacogenetic tests to regulate existing medications and to have the results on file should the patient be hospitalized.
Hospitals & ACO's
The study of drug interaction with an individual's genetic makeup can provide a critical piece of information to aid clinicians when selecting a patient's medication and initial dosage. This helps eliminate adverse drug reactions or lack of therapeutic effect under standard therapy conditions.
Drugs can be broken down too quickly or improperly, requiring a higher dosage or change in medication in many cases.
Drugs are not metabolized fast enough resulting in either too little or too much of the drug in the body.
Drugs, supplements and some foods will reduce or increase the effectiveness of the medication.
Due to mandates from CMS and other agencies, hospitals and healthcare systems increasingly need to have more detailed data on their patients as well as outcomes. Our skilled staff of regulatory experts can help our hospital partners in collecting the right data which assists in providing CMS reports that demonstrate compliance with Core Quality Measures, Value-Based Purchasing, and other important new metrics. These metrics are evaluated in determining the global reimbursement rates for hospitals.